2-(2-Chloro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, 98%, 1g

6,8-Dichlorochromone-3-carboxaldehyde>98.0%(GC)1g

Furan-3-carbonyl chloride, 95.0%, 5g

4-(4-Bromo-1H-pyrazol-1-yl)benzonitrile, 95.0%, 250mg

Benzyl 4-amino-3,3-difluoropiperidine-1-carboxylate, 98%, 1g

2-Bromo-5-fluoro-4-methylbenzaldehyde, 95.0%, 5g

Idarubicin Hydrochloride, 98%, 1mg

(3-(Benzylcarbamoyl)phenyl)boronic acid, 95.0%, 5g

N,N-Bis(1-phenylethyl)-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-12-amine, 98%, 250mg

5-Bromosalicylaldehyde, 99.00%, 100g

Symbole d'avertissement selon ISO 7010 sur le rouleau, Surface chaude, Longueur de côté 25 mm, 1 Rouleau

3-ethyl-1H-pyrazole-5-carbaldehyde, 95.0%, 250mg